Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

AAPL PEER ANALYSIS

Apple Inc. — metric-by-metric comparison with peers and the industry median

AAPLApple Inc.

🇺🇸 USA · US · Technology · Consumer Electronics

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Consumer Electronics

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
AAPLIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
AAPL+45.9%ASML+143.3%
Year-to-Date (YTD)
AAPL+13.7%ASML+78.0%
1-Year
Split-adjusted
AAPL+45.9%NVDA+24.1%MSFT-19.8%AVGO+34.3%MU+703.3%AMD+273.8%
Year-to-Date (YTD)
AAPL+13.7%NVDA+4.6%MSFT-18.9%AVGO+4.4%MU+242.0%AMD+141.8%

Key Metric Comparison

P/E

Lower is better
AAPL37.18ASML62.97Median 54.45

ROE

Higher is better
AAPL141.5%ASML52.2%Median -13.9%

Net Margin

Higher is better
AAPL27.2%ASML29.7%Median -20.1%

Revenue Growth

Higher is better
AAPL12.8%ASML9.7%Median -10.6%

P/E

Lower is better
AAPL37.18NVDA29.77MSFT23.22AVGO59.95MU22.03AMD170.57Median 54.45

ROE

Higher is better
AAPL141.5%NVDA114.3%MSFT34.0%AVGO37.3%MU66.6%AMD8.2%Median -13.9%

Net Margin

Higher is better
AAPL27.2%NVDA63.0%MSFT39.3%AVGO38.8%MU55.9%AMD13.4%Median -20.1%

Revenue Growth

Higher is better
AAPL12.8%NVDA70.7%MSFT17.9%AVGO32.3%MU167.0%AMD35.0%Median -10.6%

All Metrics

Valuation
MetricAAPLASMLInd. Median
P/E37.18●62.9754.45
P/B42.8030.26●2.57
EV/EBITDA28.60●47.8928.60
P/S10.10●18.712.53
Financial Health
MetricAAPLASMLInd. Median
Current Ratio1.071.36●1.33
Debt/Equity79.5%13.0%●3.3%
NetDebt/EBITDA0.10-0.43●-0.16
Profitability
MetricAAPLASMLInd. Median
Net Margin27.2%29.7%●-20.1%
ROE141.5%●52.2%-13.9%
ROA34.9%●21.4%-19.7%
EBITDA Margin35.4%38.7%●-2.2%
Growth + Dividend
MetricAAPLASMLInd. Median
Rev. Growth12.8%●9.7%-10.6%
NI Growth26.0%●15.0%26.0%
Div. Yield0.4%0.4%●0.0%
Payout12.7%25.7%0.0%
Valuation
MetricAAPLNVDAMSFTAVGOMUAMDInd. Median
P/E37.1829.7723.2259.9522.03●170.5754.45
P/B42.8024.317.02●20.0411.0413.252.57
EV/EBITDA28.6024.3014.36●42.9024.30104.6228.60
P/S10.1018.759.13●23.2912.3222.812.53
Financial Health
MetricAAPLNVDAMSFTAVGOMUAMDInd. Median
Current Ratio1.073.44●1.282.243.422.721.33
Debt/Equity79.5%6.6%13.7%74.0%6.3%6.0%●3.3%
NetDebt/EBITDA0.10-0.35-0.111.08-0.44-1.05●-0.16
Profitability
MetricAAPLNVDAMSFTAVGOMUAMDInd. Median
Net Margin27.2%63.0%●39.3%38.8%55.9%13.4%-20.1%
ROE141.5%●114.3%34.0%37.3%66.6%8.2%-13.9%
ROA34.9%83.0%●19.9%17.1%47.5%6.6%-19.7%
EBITDA Margin35.4%76.0%●63.1%55.7%49.8%21.6%-2.2%
Growth + Dividend
MetricAAPLNVDAMSFTAVGOMUAMDInd. Median
Rev. Growth12.8%70.7%17.9%32.3%167.0%●35.0%-10.6%
NI Growth26.0%107.9%29.6%127.0%710.8%●124.9%26.0%
Div. Yield0.4%0.0%0.9%●0.7%0.1%—0.0%
Payout12.7%0.6%20.6%40.1%0.4%—0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on AAPL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.